The Spanish Competition Authority declares that five pharmaceutical companies are not coordinating their distribution systems in Spain (Laboratorios Farmacéuticos)

During the last two years, a number of important pharmaceutical manufacturers active in the Spanish market have introduced significant changes in their distribution systems. Under the new terms of these systems, the pharmaceutical companies select a reduced number of wholesalers to work with, and discontinue pre-existing relations with the rest of the market. Some of the excluded wholesalers have initiated legal actions against the concerned pharmaceutical companies at both regulatory and competition levels. In this context, last 25 September 2008, the decision making body of the Spanish competition authority (Consejo Nacional de la Competencia or “CNC”) has adopted a decision rejecting a complaint filed by some excluded wholesalers against manufacturers for alleged illegal

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Aitor Montesa Lloreda, Angel Givaja Sanz, The Spanish Competition Authority declares that five pharmaceutical companies are not coordinating their distribution systems in Spain (Laboratorios Farmacéuticos), 25 September 2008, e-Competitions Bulletin September 2008, Art. N° 22887

Visites 5776

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues